GlassScriptPhysician profile
Lawrence Lefland
NPI 1619995214
$1,156.09
in general payments reported to CMS, 2019-2025
8 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.81 · 2020: $129 · 2021: $254 · 2022: $53.91 · 2023: $172 · 2024: $63.24 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $623.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $551.96 | 2019-2025 | Precision7, Total30 |
| Bausch & Lomb Americas INC. | $181.83 | 2025 | Miebo, Xiidra |
| Coopervision INC. | $147.45 | 2019-2023 | Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $86.01 | 2023 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $77.76 | 2024-2025 | Xdemvy |
| Rxsight INC | $45.45 | 2024 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Abb Con-Cise Optical Group LLC | $26.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Lefland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.